Enhancing violacein production in an Antarctic bacterial strain: New opportunities for biomedical use
Violacein is a valuable bioactive metabolite produced by diverse bacteria, including the Antarctic isolate Janthinobacterium sp. UV13. Despite its broad therapeutic potential, large-scale production in native producers is hindered by low yields and the concurrent synthesis of exopolysaccharides, which increases downstream processing complexity and costs. This study employed a sequential…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.